Prenatal Care and Management of Twin Pregnancy
All twin pregnancies require first-trimester ultrasound determination of chorionicity and amnionicity, as this single factor dictates the entire surveillance strategy and risk profile for the pregnancy. 1
Initial Assessment: Chorionicity Determination
The most critical first step is establishing whether the twins are monochorionic (sharing one placenta) or dichorionic (two separate placentas). This must be done in the first trimester:
- Between 7-10 weeks: Count the number of gestational sacs (nearly 100% accurate)
- Between 11-14 weeks: Look for the "lambda sign" (nearly 100% accurate for dichorionic twins)
This determination is non-negotiable because monochorionic twins carry dramatically higher risks—9-12% will develop twin-twin transfusion syndrome (TTTS), 1-5% will develop twin anemia-polycythemia sequence (TAPS), and 14-26% will have selective fetal growth restriction. 2
Surveillance Strategy: Monochorionic Twins
For monochorionic-diamniotic twins, begin ultrasound surveillance at 16 weeks gestation and continue every 2 weeks until delivery. 1 This is the most recent consensus (2024-2025) and represents enhanced recommendations.
What to Assess at Each Visit:
Starting at 16 weeks, every ultrasound must include:
- Maximum vertical pocket of amniotic fluid on both sides of the membrane
- Bladder filling status in both twins
- Umbilical artery (UA) Doppler in both twins
- Ductus venosus (DV) Doppler in both twins
- Middle cerebral artery peak systolic velocity (MCA-PSV) in both twins 2
The 2025 North American Fetal Therapy Network enhanced the 2024 SMFM guidelines by specifically adding DV and MCA-PSV measurements starting at 16 weeks, not just when complications are suspected. 2
Critical Pitfall to Avoid:
Do not rely solely on amniotic fluid assessment. The addition of MCA-PSV Doppler at every visit starting at 16 weeks allows earlier detection of TAPS, which can develop spontaneously or after laser treatment for TTTS. 1
Surveillance Strategy: Dichorionic Twins
While the provided guidelines focus heavily on monochorionic complications, dichorionic twins require:
- Monthly ultrasound examinations
- Fetal weight estimation at each visit
- Umbilical artery Doppler assessment
- Less intensive monitoring than monochorionic twins due to absence of shared placental circulation
When to Refer to Fetal Intervention Center
Immediate referral is mandatory when:
- Stage II-IV TTTS develops between 16-26 weeks (fetoscopic laser surgery is standard treatment, GRADE 1A) 1
- Stage I TTTS with maternal symptoms from polyhydramnios 1
- TAPS progresses to stage II before 32 weeks 1
- Any concern for coexisting complications
This is labeled as "Best Practice" rather than graded evidence because the complexity requires specialized expertise. 1
Post-Intervention Surveillance
If laser surgery is performed for TTTS:
- Weekly surveillance for 6 weeks post-procedure
- Then resume every-other-week surveillance
- Watch specifically for post-laser TTTS, post-laser TAPS, or fetal growth restriction 1
Timing of Delivery
For monochorionic-diamniotic twins after successful laser treatment with both twins surviving: deliver at 34-36 weeks. 1
If one twin demises after treatment: deliver the survivor at 39 weeks to avoid prematurity complications unless other indications arise. 1
For uncomplicated monochorionic twins without intervention, delivery is reasonable from 36 weeks but before 38 weeks and 6 days.
Key Algorithmic Approach
- First trimester: Determine chorionicity definitively
- If monochorionic: Start biweekly ultrasounds at 16 weeks with comprehensive Doppler assessment (UA, DV, MCA-PSV) plus amniotic fluid and bladder checks
- If any abnormality detected: Refer to fetal intervention center immediately
- If TTTS stage II-IV diagnosed 16-26 weeks: Fetoscopic laser surgery is the treatment
- Post-laser: Intensive weekly monitoring for 6 weeks, then biweekly
- Delivery timing: Based on chorionicity, intervention history, and complications
The evidence strongly emphasizes that monochorionic twin management requires specialized expertise and should involve early collaboration with fetal therapy centers, as the window for intervention (16-26 weeks) is narrow and outcomes are time-sensitive. 1